Article Versions Notes

Umstätter F, Werner J, Zerlin L, Mühlberg E, Kleist C, Klika KD, Hertlein T, Beijer B, Domhan C, Zimmermann S, et al. Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics. Pharmaceuticals. 2022; 15(2):159. https://doi.org/10.3390/ph15020159

Umstätter, Florian, Julia Werner, Leah Zerlin, Eric Mühlberg, Christian Kleist, Karel D. Klika, Tobias Hertlein, Barbro Beijer, Cornelius Domhan, Stefan Zimmermann, and et al. 2022. "Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics" Pharmaceuticals 15, no. 2: 159. https://doi.org/10.3390/ph15020159

Umstätter, F., Werner, J., Zerlin, L., Mühlberg, E., Kleist, C., Klika, K. D., Hertlein, T., Beijer, B., Domhan, C., Zimmermann, S., Ohlsen, K., Haberkorn, U., Mier, W., & Uhl, P. (2022). Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics. Pharmaceuticals, 15(2), 159. https://doi.org/10.3390/ph15020159